HAS
30
7
DNB
53
3
RRC
52
2
DO
43
3
STT
54
6
EQIX
69
4
QRVO
47
2
ECL
69
2
ROK
48
5
TGT
67
10
VIX
18
-3
VRTX
50
-3
SLB
62
2
NTRS
49
2
DOV
60
5
AAL
43
4
SRCL
44
3
GILD
65
2
PYPL
43
6
MCD
68
3
HAS
30
7
DNB
53
3
RRC
52
2
DO
43
3
STT
54
6
EQIX
69
4
QRVO
47
2
ECL
69
2
ROK
48
5
TGT
67
10
VIX
18
-3
VRTX
50
-3
SLB
62
2
NTRS
49
2
DOV
60
5
AAL
43
4
SRCL
44
3
GILD
65
2
PYPL
43
6
MCD
68
3
Financhill
Back

iBio 10K Form

Sell
6

IBIO
iBio

Last Price:
2.98
Seasonality Move:
6.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IBIO News And Ratings

See the #1 stock for the next 7 days that we like better than IBIO

IBIO Financial Statistics

Sales & Book Value

Annual Sales: $1.88M
Cash Flow: $-5.34M
Price / Cash Flow: 0
Annual Sales: $9.58
Price / Book: 0.35

Profitability

EPS (TTM): -79.00000
Net Income (TTM): $-52.63M
Gross Margin: $2.17M
Return on Equity: -232.51%
Return on Assets: -101.35%

iBio Earnings Forecast

Key iBio Financial Ratios

  • The Gross Profit Margin over the past 16 years for IBIO is 115.43%.
  • The Selling, General & Administrative Expenses for IBIO have been equal to 1,156.91% of Gross Profit Margin.
  • The Interest Expense is -0.12% of Operating Income.
  • Per Share Earnings over the last 17 years have been positive in 8 years.

iBio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Healthcare
Current Symbol: IBIO
CUSIP: 451033
Website: ibioinc.com

Debt

Debt-to-Equity Ratio: 0.96
Current Ratio: 1.11
Quick Ratio: 0.07

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IBIO Technical Analysis vs Fundamental Analysis

Sell
6
iBio (IBIO) is a Sell

Is iBio a Buy or a Sell?

  • iBio stock is rated a Sell
    The current iBio [IBIO] share price is $3.27. The Score for IBIO is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.